VIPR1-AS1: A Potential Drug Target and Biomarker (G100874007)

Target Name: VIPR1-AS1

NCBI ID: G100874007

VIPR1-AS1

Other Name(s): VIPR1 antisense RNA 1

VIPR1-AS1: A Potential Drug Target and Biomarker

Virtual screening and virtual validation are becoming increasingly important in the drug development process. These techniques allow researchers to identify potential drug targets and biomarkers, which can significantly reduce the number of drugs that need to be screened and tested. One potential drug target and biomarker that has gained attention in recent years is VIPR1-AS1.

VIPR1-AS1 is a gene that is expressed in many tissues and organs, including the brain, heart, and lungs. It is a member of the VIPR gene family, which is known for its role in cell signaling pathways. The VIPR1-AS1 gene has been shown to play a role in the regulation of cell proliferation and survival, and it has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and respiratory diseases.

As a potential drug target, VIPR1-AS1 has the potential to be used to treat a wide range of diseases. For example, VIPR1-AS1 has been shown to be involved in the regulation of cell proliferation and has been linked to the development of cancer. Therefore, it is potential to be used as a target for anti-cancer drugs. Additionally, VIPR1-AS1 has also been shown to be involved in the regulation of cell survival and has been linked to the development of neurodegenerative diseases. Therefore, it has potential as a target for drugs that target these conditions.

As a biomarker, VIPR1-AS1 has the potential to be used as a diagnostic tool for a wide range of diseases. For example, VIPR1-AS1 has been shown to be expressed in many tissues and organs, including the brain, heart, and lungs, which makes it a potential biomarker for a wide range of diseases. Additionally, VIPR1-AS1 has been shown to play a role in the regulation of cell signaling pathways, which makes it a potential biomarker for diseases that are characterized by changes in cell signaling.

In conclusion, VIPR1-AS1 is a gene that has the potential to be a drug target and biomarker. Further research is needed to fully understand its role in disease and to develop safe and effective drugs that target it.

Protein Name: VIPR1 Antisense RNA 1

The "VIPR1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VIPR1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets